Dr. New is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6560 Fannin St
Scurlock Tower, Suite 900
Houston, TX 77030Phone+1 713-441-3800Fax+1 713-790-2609- Is this information wrong?
Education & Training
- University of Texas Health Science Center at HoustonResidency, Neurology, 1985 - 1987
- University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 1985 - 1987
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurological Surgery, 1981 - 1984
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 1981 - 1981
- Baylor College of MedicineResidency, Internal Medicine, 1976 - 1979
- Northwestern University The Feinberg School of MedicineClass of 1976
Certifications & Licensure
- TX State Medical License 1985 - 2024
- IN State Medical License 2019 - 2021
- GA State Medical License 2017 - 2021
- IL State Medical License 1980 - 1987
- American Board of Psychiatry and NeurologyNeuro-Oncology
Clinical Trials
- COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors Start of enrollment: 2000 Jul 01
- Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma Start of enrollment: 2000 Jul 01
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy.Neil Chevli, Amarinthia E. Curtis, Suzanne Zein-Eldin Powell, Pamela New, E. Brian Butler, Bin S. Teh> ;Advances in Radiation Oncology. 2021 May 9
- 9 citationsCorrection: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (...Linda M. Liau, Keyoumars Ashkan, David Tran, Jian Campian, John E. Trusheim, Charles S. Cobbs, Jason Heth, Michael Salacz, Sarah A. Taylor, Stacy D. D’Andre, Fabio M. ...> ;Journal of Translational Medicine. 2018 Jun 29
- 518 citationsHER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra, Daniel Landi, Catherine Robertson, Tara Gray, Oumar Diouf, Amanda Wakefield, Alexia Ghaz...> ;JAMA Oncology. 2017 Aug 1
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: